During the past decade, Karolinska Universitetssjukhuset conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 29 clinical trials were completed, i.e. on average, 58% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 22 clinical trials were completed. i.e. 81.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karolinska Universitetssjukhuset" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Pfizer" with 8 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Kowa Research Europe" with 4 trials sponsored and "Boston Scientific Corporation" with 4 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karolinska Universitetssjukhuset" #1 collaborator was "Karolinska University Hospital" with 6 trials as a collaborator, "Haukeland University Hospital" with 3 trials as a collaborator, "Uppsala University Hospital" with 3 trials as a collaborator, "BioMS Technology Corp." with 2 trials as a collaborator and "Danderyd Hospital" with 2 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Karolinska Universitetssjukhuset" are "Dyslipidemia" (4 trials), "Atrial Fibrillation" (3 trials), "Healthy" (3 trials), "Hypercholesterolemia" (3 trials) and "Stroke" (3 trials). Many other conditions were trialed in "Karolinska Universitetssjukhuset" in a lesser frequency.

Most popular intervention types in "Karolinska Universitetssjukhuset" are "Drug" (57 trials), "Device" (9 trials), "Biological" (8 trials), "Other" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Guselkumab" (4 trials), "Ocrelizumab" (3 trials), "dabigatran etexilate" (3 trials) and "13vPnC" (2 trials). Other intervention names were less common.

The vast majority of trials in "Karolinska Universitetssjukhuset" are 73 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Karolinska Universitetssjukhuset". undefined are not yet recruiting, 17 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Karolinska Universitetssjukhuset, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Karolinska Universitetssjukhuset, 7 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 12 trials that are defined as “Not Applicable".

Karolinska Universitetssjukhuset has several departments that took part in Clinical trials: "Astrid Lindgren Pediatric Hospital" - 12 trials, "Karolinska University Hospital, Neonatology department" - 3 trials, "Stockholm South Hospital Department of Orthopeadic Surgery" - 2 trials, "Karolinska University Hospital Gastrocentrum" - 2 trials, "Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm" - 2 trials, "Karolinska Universitetssjukhuset, Onkologiska kliniken" - 2 trials